Pegylated Liposomes For Delivery Of Immunogen-Encoding Rna - EP4226941

The patent EP4226941 was granted to Glaxosmithkline on Oct 23, 2024. The application was originally filed on Aug 31, 2011 under application number EP23179901A. The patent is currently recorded with a legal status of "Granted And Under Opposition".

EP4226941

GLAXOSMITHKLINE
Application Number
EP23179901A
Filing Date
Aug 31, 2011
Status
Granted And Under Opposition
Sep 20, 2024
Grant Date
Oct 23, 2024
External Links
Slate, Register, Google Patents

Patent Summary

Patent Family

Patent Family

Patent Oppositions (5)

Patent oppositions filed by competitors challenge the validity of a granted patent. These oppositions are typically based on claims of prior art, lack of novelty, or non-obviousness. They are a key part of the process for determining a patent's strength and enforceability.

CompanyOpposition DateRepresentativeOpposition Status

Get instant alerts for new oppositions and patent status changes

ARROWHOUSEJul 23, 2025VOSSIUS & PARTNER PATENTANWALTE RECHTSANWALTE MBBADMISSIBLE
BIONTECHJul 22, 2025THOMANNADMISSIBLE
SANOFIJul 22, 2025ELKINGTON AND FIFEADMISSIBLE
WEICKMANN & WEICKMANNJul 22, 2025-ADMISSIBLE
MODERNAJul 15, 2025MEWBURN ELLISADMISSIBLE

Patent Citations (23) New

Patent citations refer to prior patents cited during different phases such as opposition or international search.

Citation PhasePublication NumberPublication Link
OPPOSITIONEP4226941
OPPOSITIONWO02095023
OPPOSITIONWO2005120152
OPPOSITIONWO2005121348
OPPOSITIONWO2006078294
OPPOSITIONWO2007047749
OPPOSITIONWO2008089112
OPPOSITIONWO2011005799
OPPOSITIONWO2011008974
OPPOSITIONWO2012006369
OPPOSITIONWO2012006376
OPPOSITIONWO2012006377
OPPOSITIONWO2012006378
OPPOSITIONWO2012030901
OPPOSITIONWO2012031043
OPPOSITIONWO2014160243
OPPOSITIONWO2017049245
OPPOSITIONWO2017075531
OPPOSITIONWO2022137133
SEARCHWO2008103276
SEARCHWO2009086558
SEARCHWO2009111088
SEARCHWO2011005799

Non-Patent Literature (NPL) Citations (76) New

NPL citations refer to non-patent references such as research papers, articles, or other publications cited during examination or opposition phases.

Citation PhaseReference TextLink
DESCRIPTION- BOXUS et al., J Virol, (20070000), vol. 81, pages 6879 - 89-
DESCRIPTION- EL OUAHABI et al., FEBS Letts, (19960000), vol. 380, pages 108 - 12-
DESCRIPTION- GIULIANI et al., Proc Natl Acad Sci USA, (20060000), vol. I, II, III, no. 29, pages 10834 - 9-
DESCRIPTION- Handbook of Experimental Immunology, Blackwell Scientific Publications, (19860000), vol. I-IV-
DESCRIPTION- HEYES et al., J Controlled Release, (20050000), vol. 107, pages 276 - 87-
DESCRIPTION- HOEKSTRA et al., Biochimica et Biophysica Acta, (20040000), vol. 1660, pages 41 - 52-
DESCRIPTION- JEFFS et al., Pharmaceutical Research, (20050000), vol. 22, no. 3, pages 362 - 372-
DESCRIPTION- JOHANNING et al., Nucleic Acids Res, (19950000), vol. 23, pages 1495 - 1501-
DESCRIPTION- MAURER et al., Biophysical Journal, (20010000), vol. 80, pages 2310 - 2326-
DESCRIPTION- "Microspheres, microcapsules & liposomes", Functional Polymer Colloids and Microparticles, Citus Books, (20020000), vol. 4-
DESCRIPTION- PERRI et al., J Virol, (20030000), vol. 77, pages 10394 - 10403-
DESCRIPTION- "Pharmaceutical Nanocarriers: Methods and Protocols", Liposomes: Methods and Protocols, Humana Press, (20090000), vol. 1-
DESCRIPTION- ROMBERG et al., Pharmaceutical Research, (20080000), vol. 25, pages 55 - 71-
DESCRIPTION- TAYLOR et al., Vaccine, (20050000), vol. 23, pages 1242 - 50-
DESCRIPTION- YONEYAMAFUJITA, Cytokine & Growth Factor Reviews, (20070000), vol. 18, pages 545 - 51-
OPPOSITION- Anonymous, "TE buffer", OpenWetWare, (20060223), pages 1 - 1, OpenWetWare, URL: https://web.archive.org/web/20060223132949/http://openwetware.org/wiki/TE_buffer, XP093302474-
OPPOSITION- Anonymous, "TE buffer", Wikipedia, pages 1 - 1, Wikipedia, URL: https://en.wikipedia.org/w/index.php?title=TE_buffer&oldid=342079184, XP093302472-
OPPOSITION- Anonymous, "Tromethamine", PubChem, (20250524), Database accession no. CID 6503, XP093303448-
OPPOSITION- Anonymous, "Zika vaccine (mRNA-1325 and mRNA-1893)", FORM S-1 REGISTRATION STATEMENT Under The Securities Act of 1933 MODERNA, INC., MODERNA, INC., pages 186 - 189, FORM S-1 REGISTRATION STATEMENT Under The Securities Act of 1933 MODERNA, INC., URL: https://www.sec.gov/Archives/edgar/data/1682852/000119312518323562/d577473ds1.htm#toc, (20240304), XP093137428-
OPPOSITION- "Chapter 6: Liposomal Adjuvants: Preparation and Formulation with Antigens", Davies Gwyn, Vaccine adjuvants: methods and protocols (Book Series: Methods in molecular biology), St. George’s University of London, London, UK, Humana Press, New York , (20100101), pages 73 - 90, ISBN 978-1-60761-584-2, XP009562797-
OPPOSITION- D13 - Declaration of Professor Liljeström submitted in the opposition proceedings concerning EP 2 590 676 B1-
OPPOSITION- D29 - Excerpt from Moderna’s 2018 10-K (pages 186-189) (no date found)-
OPPOSITION- D32 - Declaration by Kimberly Hassett-
OPPOSITION- Dolgin Elie, "TRIAL SETTLES DEBATE OVER BEST DESIGN FOR MRNA IN COVID VACCINES Ingredients for the messenger RNA vaccine made by CureVac", Nature, (20230119), vol. 613, no. 7944, pages 419 - 420, XP093087012-
OPPOSITION- Immordino Maria Laura, Dosio Franco, Cattel Luigi, "Stealth liposomes: review of the basic science, rationale, and clinical applications, existing and potential", INTERNATIONAL JOURNAL OF NANOMEDICINE, DOVE MEDICAL PRESS LTD., AUCKLAND, NZ, AUCKLAND, NZ , (20060101), vol. 1, no. 3, ISSN 1176-9114, pages 297 - 315, XP093119081-
OPPOSITION- Joseph Sambrook; David W. Russell, "Preparation of Reagents and Buffers Used in Molecular Cloning", Joseph Sambrook; David W. Russell, SAMBROOK J., RUSSELL D.W., MOLECULAR CLONING : A LABORATORY MANUAL, New York; US , COLD SPRING HARBOR PRESS , (20010101), pages A1.1 - A1.29, 024521, ISBN 978-0-87969-576-7, XP009562386-
OPPOSITION- Lowe Derek, "CureVac Comes Around", Science, pages 1 - 5, Science , URL: https://www.science.org/content/blog-post/curevac-comes-around, (20240223), XP093134298-
OPPOSITION- Sambrook et al., "Commonly Used Buffers", Sambrook et al., Sambrook et al., Molecular cloning : a laboratory manual, Plainview, NY , Cold Spring Harbor Laboratory Press , (19890101), vol. 3, pages B.20 - B.21, ISBN 0-87969-309-6, XP009562385-
OPPOSITION- Shayne Cox, Steve Pascolo, "Chapter 7.2. Plasmid DNA and Messenger RNA for Therapy", Shayne Cox, Steve Pascolo, Cox & Pascolo, Handbook of Pharmaceutical Biotechnology, John Wiley & Sons , (20070601), pages 971 - 1011, doi:10.1002/9780470117118.ch07b, ISBN 978-0-471-21386-4, XP055626043
OPPOSITION- Nicholas W. Warne, "Formulation Development of Phase 1-2 Biopharmaceuticals: An Efficient and Timely Approach : Jameel/Manufacturing Biopharmaceuticals", Nicholas W. Warne, Jameel Feroz ; Hershenson Susan, Formulation and Process Development Strategies for Manufacturing Biopharmaceuticals, Hoboken, N.J. , John Wiley & Sons, Inc. , (20100726), pages 147 - 159, doi:10.1002/9780470595886.ch6, ISBN 978-0-470-11812-2, XP055752685
OPPOSITION- Frédéric Martinon, Sivadasan Krishnan, Gerlinde Lenzen, Rémy Magné, Elisabeth Gomard, Jean-Gérard Guillet, Jean-Paul Lévy, Pierre Meulien, "Induction of virus-specific cytotoxic T lymphocytes in vivo by liposome-entrapped mRNA.", European Journal of Immunology, Wiley-VCH, Hoboken, USA, Hoboken, USA, (19930701), vol. 23, no. 7, doi:10.1002/eji.1830230749, ISSN 0014-2980, pages 1719 - 1722, XP002660045
OPPOSITION- LI W, ET AL, "Low-pH-sensitive poly(ethylene glycol)(PEG)-stabilized plasmid nanolipoparticles: effects of PEG chain length, lipid composition and assembly conditions on gene delivery", The Journal of Gene Medicine, John Wiley & Sons, Inc, US, US , (20050101), vol. 7, no. 1, doi:10.1002/JGM.634, ISSN 1099-498X, pages 67 - 79, XP008126013
OPPOSITION- Nielsen, Henrik, "Chapter 2: Working with RNA", Nielsen, Henrik, Nielsen, H., Methods in Molecular Biology, Totowa, NJ, Humana Press, (20110101), vol. 703, pages 15 - 28, doi:10.1007/978-1-59745-248-9_2, ISSN 1940-6029, ISBN 978-1-59745-248-9, XP009562337
OPPOSITION- Pascolo Steve, "Vaccination with messenger RNA (mRNA)", Toll-like receptors (TLRs) and innate immunity, Berlin [u.a.] : Springer, DE, DE , (20080101), vol. 183, doi:10.1007/978-3-540-72167-3_11, ISBN 978-3-540-72166-6, pages 221 - 235, XP001538300
OPPOSITION- H. Ren, Boulikas T, S61ing A, Warnke P C, Rainov N G, "Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene — a phase I/II clinical protocol", Journal of Neuro-Oncology, Boston, (20030801), vol. 64, no. 1-2, doi:10.1007/BF02700029, ISSN 0167-594X, pages 147 - 154, XP055682947
OPPOSITION- Lloyd B. Jeffs ; Lorne R. Palmer ; Ellen G. Ambegia ; Cory Giesbrecht ; Shannon Ewanick ; Ian MacLachlan, "A Scalable, Extrusion-Free Method for Efficient Liposomal Encapsulation of Plasmid DNA", Pharmaceutical Research, Kluwer Academic Publishers-Plenum Publishers, NL, NL , (20050301), vol. 22, no. 3, doi:10.1007/s11095-004-1873-z, ISSN 1573-904X, pages 362 - 372, XP019370801
OPPOSITION- Rivest Véronique; Phivilay Alix; Julien Carl; Bélanger Sandra; Tremblay Cyntia; Émond Vincent; Calon Frédéric, "Novel Liposomal Formulation for Targeted Gene Delivery", Pharmaceutical Research, Springer Berlin Heidelberg, Berlin/Heidelberg, Berlin/Heidelberg, (20070324), vol. 24, no. 5, doi:10.1007/s11095-006-9224-x, ISSN 0724-8741, pages 981 - 990, XP037855480
OPPOSITION- Wilson, T. ; Papahadjopoulos, D. ; Taber, R., "The introduction of poliovirus RNA into cells via lipid vesicles (liposomes)", Cell, Elsevier, Amsterdam NL, Amsterdam NL , (19790501), vol. 17, no. 1, doi:10.1016/0092-8674(79)90296-4, ISSN 0092-8674, pages 77 - 84, XP023910555
OPPOSITION- Zhou, X. ; Berglund, P. ; Rhodes, G. ; Parker, S.E. ; Jondal, M. ; Liljestrom, P., "Self-replicating Semliki Forest virus RNA as recombinant vaccine", Vaccine, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (19941201), vol. 12, no. 16, doi:10.1016/0264-410X(94)90074-4, ISSN 0264-410X, pages 1510 - 1514, XP023711634
OPPOSITION- Santos, A.O. ; da Silva, L.C.G. ; Bimbo, L.M. ; de Lima, M.C.P. ; Simoes, S. ; Moreira, J.N., "Design of peptide-targeted liposomes containing nucleic acids", Biochimica et Biophysica Acta, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20100301), vol. 1798, no. 3, doi:10.1016/j.bbamem.2009.12.001, ISSN 0005-2736, pages 433 - 441, XP026916011
OPPOSITION- Kim, J.Y. ; Kim, J.K. ; Park, J.S. ; Byun, Y. ; Kim, C.K., "The use of PEGylated liposomes to prolong circulation lifetimes of tissue plasminogen activator", Biomaterials, Elsevier, AMSTERDAM, NL, AMSTERDAM, NL , (20091001), vol. 30, no. 29, doi:10.1016/j.biomaterials.2009.07.021, ISSN 0142-9612, pages 5751 - 5756, XP026470001
OPPOSITION- Han, H.D. Shin, B.C. Choi, H.S., "Doxorubicin-encapsulated thermosensitive liposomes modified with poly(N-isopropylacrylamide-co-acrylamide): Drug release behavior and stability in the presence of serum", European journal of pharmaceutics and biopharmaceutics, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM., NL, NL , (20060101), vol. 62, no. 1, doi:10.1016/j.ejpb.2005.07.006, ISSN 0939-6411, pages 110 - 116, XP005191340
OPPOSITION- Yamamoto A. et al, "Current prospects for mRNA gene delivery", European journal of pharmaceutics and biopharmaceutics, ELSEVIER SCIENCE PUBLISHERS B.V., AMSTERDAM., NL, NL , (20090301), vol. 71, no. 3, doi:10.1016/j.ejpb.2008.09.016, ISSN 0939-6411, pages 484 - 489, XP025992169
OPPOSITION- Hatzi, P. Mourtas, S. G. Klepetsanis, P. Antimisiaris, S.G., "Integrity of liposomes in presence of cyclodextrins: Effect of liposome type and lipid composition", International Journal of Pharmaceutics, Elsevier, AMSTERDAM, NL, AMSTERDAM, NL, (20070224), vol. 333, no. 1-2, doi:10.1016/j.ijpharm.2006.09.059, ISSN 0378-5173, pages 167 - 176, XP005904216
OPPOSITION- Mignet, N. ; Richard, C. ; Seguin, J. ; Largeau, C. ; Bessodes, M. ; Scherman, D., "Anionic pH-sensitive pegylated lipoplexes to deliver DNA to tumors", International Journal of Pharmaceutics, Elsevier, AMSTERDAM, NL, AMSTERDAM, NL, (20080901), vol. 361, no. 1-2, doi:10.1016/j.ijpharm.2008.05.017, ISSN 0378-5173, pages 194 - 201, XP023316077
OPPOSITION- Kim, H.K. ; Davaa, E. ; Myung, C.S. ; Park, J.S., "Enhanced siRNA delivery using cationic liposomes with new polyarginine-conjugated PEG-lipid", International Journal of Pharmaceutics, Elsevier, AMSTERDAM, NL, AMSTERDAM, NL, (20100615), vol. 392, no. 1-2, doi:10.1016/j.ijpharm.2010.03.047, ISSN 0378-5173, pages 141 - 147, XP027044515
OPPOSITION- Schoenmaker Linde, Witzigmann Dominik, Kulkarni Jayesh A., Verbeke Rein, Kersten Gideon, Jiskoot Wim, Crommelin Daan J.A., "mRNA-lipid nanoparticle COVID-19 vaccines: Structure and stability", International Journal of Pharmaceutics, Elsevier, AMSTERDAM, NL, AMSTERDAM, NL, (20210501), vol. 601, doi:10.1016/j.ijpharm.2021.120586, ISSN 0378-5173, page 120586, XP055828800
OPPOSITION- James Heyes et al, "'Cationic lipid saturation influences intracellular delivery of encapsulated nucleic acids", Journal of Controlled Release, Elsevier, NL, NL , (20050101), vol. 107, no. 2, doi:10.1016/j.jconrel.2005.06.014, ISSN 0168-3659, pages 276 - 287, XP008157522
OPPOSITION- Obata, Y. ; Tajima, S. ; Takeoka, S., "Evaluation of pH-responsive liposomes containing amino acid-based zwitterionic lipids for improving intracellular drug delivery in vitro and in vivo", Journal of Controlled Release, Elsevier, NL, NL , (20100303), vol. 142, no. 2, doi:10.1016/j.jconrel.2009.10.023, ISSN 0168-3659, pages 267 - 276, XP026905290
OPPOSITION- Wang, D. Christopher, M.E. Nagata, L.P. Zabielski, M.A. Li, H. Wong, J.P. Samuel, J., "Intranasal immunization with liposome-encapsulated plasmid DNA encoding influenza virus hemagglutinin elicits mucosal, cellular and humoral immune responses", Journal of clinical virology, ELSEVIER, AMSTERDAM, NL, NL , (20041201), vol. 31, doi:10.1016/j.jcv.2004.09.013, ISSN 1386-6532, pages 99 - 106, XP004660136
OPPOSITION- Hassett Kimberly J., Benenato Kerry E., Jacquinet Eric, Lee Aisha, Woods Angela, Yuzhakov Olga, Himansu Sunny, Deterling Jessica, Geilich Benjamin M., Ketova Tatiana, Mihai Cosmin, Lynn Andy, Mcfadyen Iain, Moore Melissa J., Senn Joseph J., Stanton Matthew G., Almarsson Örn, Ciaramella Giuseppe, Brito Luis A., "Optimization of Lipid Nanoparticles for Intramuscular Administration of mRNA Vaccines", Molecular Therapy-Nucleic Acids, Cell Press, US, US , (20190415), vol. 15, doi:10.1016/j.omtn.2019.01.013, ISSN 2162-2531, pages 1 - 11, XP055815007
OPPOSITION- Saxena, S. ; Sonwane, A.A. ; Dahiya, S.S. ; Patel, C.L. ; Saini, M. ; Rai, A. ; Gupta, P.K., "Induction of immune responses and protection in mice against rabies using a self-replicating RNA vaccine encoding rabies virus glycoprotein", VETERINARY MICROBIOLOGY, Elsevier BV, NL, NL , (20090414), vol. 136, no. 1-2, doi:10.1016/j.vetmic.2008.10.030, ISSN 0378-1135, pages 36 - 44, XP026071306
OPPOSITION- MONNARD P-A, OBERHOLZER T, LUISI P-L, "Entrapment of nucleic acids in liposomes.", Biochimica et Biophysica Acta, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (19971002), vol. 1329, no. 1, doi:10.1016/S0005-2736(97)00066-7, ISSN 0005-2736, pages 39 - 50, XP002220428
OPPOSITION- Wong, J.P. Zabielski, M.A. Schmaltz, F.L. Brownlee, G.G. Bussey, L.A. Marshall, K. Borralho, T. Nagata, L.P., "DNA vaccination against respiratory influenza virus infection", Vaccine, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (20010321), vol. 19, no. 17-19, doi:10.1016/S0264-410X(00)00474-6, ISSN 0264-410X, pages 2461 - 2467, XP004231066
OPPOSITION- LEITNER W W, YING H, RESTIFO N P, "DNA AND RNA-BASED VACCINES: PRINCIPLES, PROGRESS AND PROSPECTS", Vaccine, ELSEVIER, AMSTERDAM, NL, AMSTERDAM, NL , (19991210), vol. 18, no. 9-10, doi:10.1016/S0264-410X(99)00271-6, ISSN 0264-410X, pages 765 - 777, XP002943399
OPPOSITION- KARIKÓ KATALIN ET AL, "Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability.", Molecular Therapy, Nature Publishing Group, GB, GB , (20081101), vol. 16, no. 11, doi:10.1038/mt.2008.200, ISSN 1525-0024, pages 1833 - 1840, XP002598556
OPPOSITION- Zimmermann Tracy S., Lee Amy C. H., Akinc Akin, Bramlage Birgit, Bumcrot David, Fedoruk Matthew N., Harborth Jens, Heyes James A., Jeffs Lloyd B., John Matthias, Judge Adam D., Lam Kieu, Mcclintock Kevin, Nechev Lubomir V., Palmer Lorne R., Racie Timothy, Röhl Ingo, Seiffert Stephan, Shanmugam Sumi, Sood Vandana, Soutschek Jürgen, Toudjarska Ivanka, Wheat Amanda J., Yaworski Ed, Zedalis William, Koteliansky Victor, Manoharan Muthiah, Vornlocher Hans-Peter, Maclachlan Ian, "RNAi-mediated gene silencing in non-human primates", Nature, Springer Nature Limited, London, London, (20060101), vol. 441, doi:10.1038/nature04688, ISSN 0028-0836, pages 111 - 114, XP093134286
OPPOSITION- Akinc Akin; Maier Martin A.; Manoharan Muthiah; Fitzgerald Kevin; Jayaraman Muthusamy; Barros Scott; Ansell Steven; Du Xinyao; Hope Michael J.; Madden Thomas D.; Mui Barbara L.; Semple Sean C.; Tam Ying K.; Ciufolini Marco; Witzigmann Dominik; Kulkarni Jayesh A.; van der Meel Roy; Cullis Pieter R., "The Onpattro story and the clinical translation of nanomedicines containing nucleic acid-based drugs", nature nanotechnology, Nature Pub. Group, Inc., London, London , (20191201), vol. 14, no. 12, doi:10.1038/s41565-019-0591-y, ISSN 1748-3387, pages 1084 - 1087, XP036953174
OPPOSITION- Wheeler J J; Palmer L; Ossanlou M; MacLachlan I; Graham R W; Zhang Y P; Hope M J; Scherrer P; Cullis P R, "Stabilized plasmid-lipid particles: construction and characterization", Gene Therapy, Nature Publishing Group, London, GB, GB , (19990201), vol. 6, no. 2, doi:10.1038/sj.gt.3300821, ISSN 0969-7128, pages 271 - 281, XP037770556
OPPOSITION- Tam P; Monck M; Lee D; Ludkovski O; Leng E C; Clow K; Stark H; Scherrer P; Graham R W; Cullis P R, "Stabilized plasmid-lipid particles for systemic gene therapy", Gene Therapy, Nature Publishing Group, London, GB, GB , (20001101), vol. 7, no. 21, doi:10.1038/sj.gt.3301308, ISSN 0969-7128, pages 1867 - 1874, XP037771597
OPPOSITION- Mcardle Fiona A., Meehan Catherine J, "Determination of tromethamine in an eye-care pharmaceutical by capillary electrophoresis", Analyst, Royal Society of Chemistry, UK, UK , (19980801), vol. 123, no. 8, doi:10.1039/a802417k, ISSN 0003-2654, pages 1757 - 1760, XP093303451
OPPOSITION- HOFLAND H E J, SHEPHARD L, SULLIVAN S M, "Formation of stable cationic lipid/DNA complexes for gene transfer.", Proceedings of the National Academy of Sciences (PNAS), National Academy of Sciences, (19960709), vol. 93, no. 14, doi:10.1073/pnas.93.14.7305, ISSN 0027-8424, pages 7305 - 7309, XP002555917
OPPOSITION- Norbert Pardi, Et Al., "Nucleoside-modified mRNA vaccines induce potent T follicular helper and germinal center B cell responses", Journal of Experimental Medicine, Rockefeller University Press, US, US , (20180604), vol. 215, no. 6, doi:10.1084/jem.20171450, ISSN 0022-1007, pages 1571 - 1588, XP055545604
OPPOSITION- Fleeton, Et Al., "Self-replicative vaccines elicit protection against influenza A virus, respiratory syncytial virus and tickborne encephalitis", J. Infectious Diseases, (20010101), vol. 183, doi:10.1086/319857, pages 1395 - 1398, XP055702690
OPPOSITION- W-Z Zhou, D S B Hoon, S K S Huang, et al, "RNA melanoma vaccine: induction of antitumor immunity by human glycoprotein 100 mRNA immunization.", HUMAN GENE THERAPY, Mary Ann Liebert, Inc. Publishers, GB, GB , (19991101), vol. 10, no. 16, doi:10.1089/10430349950016762, ISSN 1043-0342, pages 2719 - 2724, XP002660042
OPPOSITION- R A DURST, B R STAPLES, "Tris-tris-HCl: a standard buffer for use in the physiologic pH range", Clinical Chemistry, Oxford University Press, US, US , (19720301), vol. 18, no. 3, doi:10.1093/clinchem/18.3.206, ISSN 0009-9147, pages 206 - 208, XP009562387
OPPOSITION- PUYAL C., ET AL., "A NEW CATIONIC LIPOSOME ENCAPSULATING GENETIC MATERIAL A POTENTIAL DELIVERY SYSTEM FOR POLYNUCLEOTIDES.", European Journal of Biochemistry, Published by Springer-Verlag on behalf of the Federation of European Biochemical Societies, Hoboken, USA, Hoboken, USA, (19950315), vol. 228., no. 03., doi:10.1111/j.1432-1033.1995.0697m.x, ISSN 0014-2956, pages 697 - 703., XP000602770
OPPOSITION- STRAUSS, J.H. & STRAUSS, E.G., "The Alphaviruses: gene expression, replication, and evolution", MICROBIOLOGICAL REVIEWS, AMERICAN SOCIETY FOR MICROBIOLOGY, WASHINGTON, DC, US, US , (19940901), vol. 58., no. 03., doi:10.1128/mr.58.3.491-562.1994, ISSN 0146-0749, pages 491 - 562, XP002108834
OPPOSITION- S. Sonoke, T. Ueda, K. Fujiwara, Y. Sato, K. Takagaki, K. Hirabayashi, T. Ohgi, J. Yano, "Tumor Regression in Mice by Delivery of Bcl-2 Small Interfering RNA with Pegylated Cationic Liposomes", Cancer research, University of Chicago Press, (20081101), vol. 68, no. 21, doi:10.1158/0008-5472.CAN-08-0127, ISSN 0008-5472, pages 8843 - 8851, XP055046252
OPPOSITION- Ian MacLachlan, "CHAPTER 9. Liposomal Formulations for Nucleic Acid Delivery", Antisense Drug Technology: Principles, Strategies, and Applications, Second Edition, CRC Press, (20070725), pages 237 - 270, doi:10.1201/9780849387951, ISBN 0-8493-8796-5, XP093133162
OPPOSITION- Pascolo S, "Vaccination with messenger RNA", Pascolo S, Saltzman et al., DNA vaccines : methods and protocols, Humana Press , (20060101), vol. 127, pages 23 - 40, doi:10.1385/1-59745-168-1:23, ISBN 1-58829-484-6, XP009117840
OPPOSITION- Pascolo S, "Messenger RNA-based vaccines", EXPERT OPINION ON BIOLOGICAL THERAPY, Informa Healthcare, (20040801), vol. 4, no. 8, doi:10.1517/14712598.4.8.1285, ISSN 1471-2598, pages 1285 - 1294, XP009095328
OPPOSITION- Morais Pedro, Adachi Hironori, Yu Yi-Tao, "The Critical Contribution of Pseudouridine to mRNA COVID-19 Vaccines", Frontiers in Cell and Developmental Biology, vol. 9, doi:10.3389/fcell.2021.789427, XP055885272
OPPOSITION- Xu Yingying, Yuen Pak-Wai, Lam Jenny, "Intranasal DNA Vaccine for Protection against Respiratory Infectious Diseases: The Delivery Perspectives", Pharmaceutics, MDPI AG, Switzerland, Switzerland, (20140901), vol. 6, no. 3, doi:10.3390/pharmaceutics6030378, ISSN 1999-4923, pages 378 - 415, XP093302501
OPPOSITION- Kenneth Lundstrom, "Alphaviruses in Gene Therapy", Viruses, MDPI, CH, CH , (20090601), vol. 1, no. 1, doi:10.3390/v1010013, ISSN 1999-4915, pages 13 - 25, XP055496283
SEARCH- MOCKEY M ET AL, "mRNA-based cancer vaccine: prevention of B16 melanoma progression and metastasis by systemic injection of MART1 mRNA histidylated lipopolyplexes", CANCER GENE THERAPY, (200709), vol. 14, no. 9, ISSN 0929-1903, pages 802 - 814, XP055007324 [A] 1-9 * page 804, column l, paragraph 4 *

Download Citation Report

Get a free citation report including examiner, opposition, and international search citations.

Get Citation Report

Dossier Documents

The dossier documents provide a comprehensive record of the patent’s prosecution history - including filings, correspondence, and decisions made by patent offices - and are crucial for understanding the patent’s legal journey and any challenges it may have faced during examination.

  • Date

    Description

  • Get instant alerts for new documents